{"id":"https://openalex.org/W2013264100","doi":"https://doi.org/10.1172/jci0214891","title":"Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis","display_name":"Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis","alternate_titles":[],"publication_year":2002,"publication_date":"2002-01-15","ids":{"openalex":"https://openalex.org/W2013264100","doi":"https://doi.org/10.1172/jci0214891","mag":"2013264100","pmid":"https://pubmed.ncbi.nlm.nih.gov/11805141","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/150847"},"language":"en","primary_location":{"id":"doi:10.1172/jci0214891","doi":"https://doi.org/10.1172/jci0214891","is_oa":false,"landing_page_url":"https://doi.org/10.1172/jci0214891","pdf_url":null,"source":{"id":"https://openalex.org/S114430552","display_name":"Journal of Clinical Investigation","issn_l":"0021-9738","issn":["0021-9738","1558-8238"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320279","host_organization_name":"American Society for Clinical Investigation","host_organization_lineage":["https://openalex.org/P4310320279"],"host_organization_lineage_names":["American Society for Clinical Investigation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Investigation","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2013264100"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.jci.org/articles/view/14891/files/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038502087","display_name":"Marzia Pennati","orcid":"https://orcid.org/0000-0002-6181-2681","observed_orcids":["https://orcid.org/0000-0002-6181-2681"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marzia Pennati","raw_affiliation_strings":["Department of Experimental Oncology , Unit 10 , Istituto Nazionale per lo Studio e la Cura dei Tumori , Milan , Italy","Fondazione IRCCS Istituto Nazionale dei Tumori"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology , Unit 10 , Istituto Nazionale per lo Studio e la Cura dei Tumori , Milan , Italy","institution_ids":["https://openalex.org/I4210156707"]},{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031883816","display_name":"Gennaro Colella","orcid":"https://orcid.org/0000-0001-9132-8375","observed_orcids":["https://orcid.org/0000-0001-9132-8375"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gennaro Colella","raw_affiliation_strings":["Department of Experimental Oncology , Unit 10 , Istituto Nazionale per lo Studio e la Cura dei Tumori , Milan , Italy","Istituto Nazionale Ricerca Cancer, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology , Unit 10 , Istituto Nazionale per lo Studio e la Cura dei Tumori , Milan , Italy","institution_ids":["https://openalex.org/I4210156707"]},{"raw_affiliation_string":"Istituto Nazionale Ricerca Cancer, Milan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036195733","display_name":"Marco Folini","orcid":"https://orcid.org/0000-0002-1811-4407","observed_orcids":["https://orcid.org/0000-0002-1811-4407"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco Folini","raw_affiliation_strings":["Department of Experimental Oncology , Unit 10 , Istituto Nazionale per lo Studio e la Cura dei Tumori , Milan , Italy","Fondazione IRCCS Istituto Nazionale dei Tumori"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology , Unit 10 , Istituto Nazionale per lo Studio e la Cura dei Tumori , Milan , Italy","institution_ids":["https://openalex.org/I4210156707"]},{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085271923","display_name":"Lorenzo Citti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lorenzo Citti","raw_affiliation_strings":["Istituto di Mutagenesi e Differenziamento , Pisa , Italy","Istituto Nazionale Ricerca Cancer, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Mutagenesi e Differenziamento , Pisa , Italy","institution_ids":[]},{"raw_affiliation_string":"Istituto Nazionale Ricerca Cancer, Milan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026775250","display_name":"Maria Grazia Daidone","orcid":"https://orcid.org/0000-0002-4786-1321","observed_orcids":["https://orcid.org/0000-0002-4786-1321"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Grazia Daidone","raw_affiliation_strings":["Department of Experimental Oncology , Unit 10 , Istituto Nazionale per lo Studio e la Cura dei Tumori , Milan , Italy","Fondazione IRCCS Istituto Nazionale dei Tumori"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology , Unit 10 , Istituto Nazionale per lo Studio e la Cura dei Tumori , Milan , Italy","institution_ids":["https://openalex.org/I4210156707"]},{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075803217","display_name":"Nadia Zaffaroni","orcid":"https://orcid.org/0000-0002-4669-0890","observed_orcids":["https://orcid.org/0000-0002-4669-0890"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Nadia Zaffaroni","raw_affiliation_strings":["Department of Experimental Oncology , Unit 10 , Istituto Nazionale per lo Studio e la Cura dei Tumori , Milan , Italy","Istituto Nazionale per lo Studio e la Cura dei Tumori , Via Venezian 1 , 20133 Milano , Italy","Fondazione IRCCS Istituto Nazionale dei Tumori"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology , Unit 10 , Istituto Nazionale per lo Studio e la Cura dei Tumori , Milan , Italy","institution_ids":["https://openalex.org/I4210156707"]},{"raw_affiliation_string":"Istituto Nazionale per lo Studio e la Cura dei Tumori , Via Venezian 1 , 20133 Milano , Italy","institution_ids":["https://openalex.org/I4210156707"]},{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori","institution_ids":["https://openalex.org/I4210156707"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5075803217"],"corresponding_institution_ids":["https://openalex.org/I4210156707"],"apc_list":{"value":5200,"currency":"USD","value_usd":5200},"apc_paid":null,"fwci":2.9336,"has_fulltext":true,"cited_by_count":118,"citation_normalized_percentile":{"value":0.91820836,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"109","issue":"2","first_page":"285","last_page":"286"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.6147000193595886,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.6147000193595886,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.3142000138759613,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.02280000038444996,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/survivin","display_name":"survivin","score":0.8709999918937683},{"id":"https://openalex.org/keywords/hammerhead-ribozyme","display_name":"hammerhead ribozyme","score":0.8529999852180481},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7710000276565552},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9890000224113464},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8849999904632568},{"id":"https://openalex.org/keywords/inhibitor-of-apoptosis-proteins","display_name":"inhibitor of apoptosis proteins","score":0.9190000295639038},{"id":"https://openalex.org/keywords/caspase-inhibition","display_name":"caspase inhibition","score":0.8830000162124634},{"id":"https://openalex.org/keywords/gene-silencing","display_name":"gene silencing","score":0.5590000152587891},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.328000009059906},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.5070000290870667},{"id":"https://openalex.org/keywords/cell-proliferation-inhibition","display_name":"cell proliferation inhibition","score":0.3440000116825104},{"id":"https://openalex.org/keywords/cell-migration-inhibition","display_name":"cell migration inhibition","score":0.3479999899864197},{"id":"https://openalex.org/keywords/cell-adhesion","display_name":"cell adhesion","score":0.4359999895095825}],"concepts":[{"id":"https://openalex.org/C2775975398","wikidata":"https://www.wikidata.org/wiki/Q906904","display_name":"Survivin","level":3,"score":0.9542924165725708},{"id":"https://openalex.org/C76346623","wikidata":"https://www.wikidata.org/wiki/Q205858","display_name":"Ribozyme","level":4,"score":0.7117569446563721},{"id":"https://openalex.org/C2779792011","wikidata":"https://www.wikidata.org/wiki/Q3817690","display_name":"Hammerhead ribozyme","level":5,"score":0.6856165528297424},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5909188985824585},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.519774854183197},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4981107711791992},{"id":"https://openalex.org/C2777408456","wikidata":"https://www.wikidata.org/wiki/Q174299","display_name":"Inhibitor of apoptosis","level":4,"score":0.49498456716537476},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.4495658576488495},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4364355504512787},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.42102891206741333},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.41710197925567627},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.37310659885406494},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.3494369387626648},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.23994645476341248},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.22529393434524536},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1676625907421112},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15209853649139404},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07385134696960449},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.05963015556335449}],"mesh":[{"descriptor_ui":"D000077022","descriptor_name":"Survivin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002868","descriptor_name":"Chromosomal Proteins, Non-Histone","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008869","descriptor_name":"Microtubule-Associated Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015853","descriptor_name":"Cysteine Proteinase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016337","descriptor_name":"RNA, Catalytic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016337","descriptor_name":"RNA, Catalytic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020169","descriptor_name":"Caspases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051034","descriptor_name":"Inhibitor of Apoptosis Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053148","descriptor_name":"Caspase 3","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1172/jci0214891","doi":"https://doi.org/10.1172/jci0214891","is_oa":false,"landing_page_url":"https://doi.org/10.1172/jci0214891","pdf_url":null,"source":{"id":"https://openalex.org/S114430552","display_name":"Journal of Clinical Investigation","issn_l":"0021-9738","issn":["0021-9738","1558-8238"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320279","host_organization_name":"American Society for Clinical Investigation","host_organization_lineage":["https://openalex.org/P4310320279"],"host_organization_lineage_names":["American Society for Clinical Investigation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Investigation","raw_type":"journal-article"},{"id":"doi:10.1172/jci14891","doi":"https://doi.org/10.1172/jci14891","is_oa":true,"landing_page_url":"https://doi.org/10.1172/jci14891","pdf_url":"http://www.jci.org/articles/view/14891/files/pdf","source":{"id":"https://openalex.org/S114430552","display_name":"Journal of Clinical Investigation","issn_l":"0021-9738","issn":["0021-9738","1558-8238"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320279","host_organization_name":"American Society for Clinical Investigation","host_organization_lineage":["https://openalex.org/P4310320279"],"host_organization_lineage_names":["American Society for Clinical Investigation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Investigation","raw_type":"journal-article"},{"id":"pmid:11805141","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11805141","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical investigation","raw_type":"Letter"},{"id":"pmh:oai:pubmedcentral.nih.gov:150847","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC150847/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Invest","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1172/jci14891","doi":"https://doi.org/10.1172/jci14891","is_oa":true,"landing_page_url":"https://doi.org/10.1172/jci14891","pdf_url":"http://www.jci.org/articles/view/14891/files/pdf","source":{"id":"https://openalex.org/S114430552","display_name":"Journal of Clinical Investigation","issn_l":"0021-9738","issn":["0021-9738","1558-8238"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320279","host_organization_name":"American Society for Clinical Investigation","host_organization_lineage":["https://openalex.org/P4310320279"],"host_organization_lineage_names":["American Society for Clinical Investigation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Investigation","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2013264100.pdf","grobid_xml":"https://content.openalex.org/works/W2013264100.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W67676209","https://openalex.org/W1768187423","https://openalex.org/W1984545745","https://openalex.org/W1985068997","https://openalex.org/W2035523654","https://openalex.org/W2059421587","https://openalex.org/W2072337591","https://openalex.org/W2154795389","https://openalex.org/W2155523608","https://openalex.org/W2737785069"],"related_works":["https://openalex.org/W2021353268","https://openalex.org/W2140898058","https://openalex.org/W2476519806","https://openalex.org/W1969075574","https://openalex.org/W2170479207","https://openalex.org/W2154795389","https://openalex.org/W2010726130","https://openalex.org/W2150558353","https://openalex.org/W2418160059","https://openalex.org/W1999605095"],"abstract_inverted_index":{"Survivin":[0,473],"is":[1,16,34,50,625],"a":[2,69,82,106,110,174,182,189,201,216,303,319,397,509,622,629,638,650,667,704,759,769],"structurally":[3],"unique":[4],"member":[5],"of":[6,9,13,22,27,54,79,113,122,136,160,181,191,204,222,256,337,343,358,368,403,422,428,450,520,528,533,550,568,658,676,692,708,717,767],"the":[7,37,55,77,101,157,161,165,170,207,219,223,233,249,254,257,263,273,335,341,352,359,366,393,401,442,451,467,486,498,517,534,566,643,655,659,720,726,731,764],"inhibitor":[8],"apoptosis":[10,28,116,530,564],"(IAP)":[11],"family":[12],"proteins":[14],"that":[15,48,103,604,619,743],"potentially":[17],"involved":[18],"in":[19,52,63,92,100,117,129,143,169,218,323,328,371,392,400,408,436,460,466,476,514,538,553,565,584,595,605,634,734],"both":[20,177],"control":[21,231,255,683,712],"cell":[23,120,141,267,482,556,593,722],"division":[24],"and":[25,125,164,227,243,260,297,310,364,413,431,462,480,492,579,587,633,690,715,738],"inhibition":[26,135,151,339,620],"(1).":[29],"Specifically,":[30],"its":[31,425],"antiapoptotic":[32,572],"function":[33],"related":[35],"to":[36,39,76,283,346,424,561,590,627,665,752,762],"ability":[38],"directly":[40],"or":[41,292,496],"indirectly":[42],"inhibit":[43],"caspases":[44],"(2).":[45],"The":[46],"notion":[47],"survivin":[49,80,114,137,150,171,192,306,324,338,535,551,608,677,745],"overexpressed":[51],"most":[53],"common":[56],"human":[57,118,264,644,771],"tumors":[58],"(3,":[59],"4)":[60],"but":[61,612],"absent":[62],"normal":[64],"adult":[65],"tissues":[66],"with":[67,105,194,355,374,485,497,508,516,636,649,682,730],"only":[68],"few":[70],"exceptions":[71],"(5,":[72],"6)":[73],"has":[74],"led":[75],"proposal":[78],"as":[81,230,446,577,685],"promising":[83],"therapeutic":[84],"target":[85],"for":[86,149,361],"novel":[87],"anticancer":[88],"therapies":[89],"(7).":[90],"Indeed,":[91],"October":[93],"2001,":[94],"Mesri":[95],"et":[96,522],"al.":[97,523],"(8)":[98],"reported":[99,545],"JCI":[102],"infection":[104],"replication-deficient":[107],"adenovirus":[108],"encoding":[109],"Thr34\u2192Ala":[111,536],"mutant":[112,499,537],"caused":[115],"tumor":[119,127,144,597],"lines":[121],"different":[123,353],"histology":[124],"reduced":[126],"growth":[128],"xenograft":[130],"breast":[131],"cancer":[132,646],"models.":[133],"Moreover,":[134],"expression":[138,251,325,475,532,552,609,678,695,746],"enhanced":[139],"taxol-induced":[140],"death":[142,594],"cells.\r\n\r\nAs":[145],"an":[146,672],"alternative":[147],"strategy":[148,761],"we":[152,276,350,641,662],"developed":[153],"hammerhead":[154],"ribozymes":[155,178,488],"targeting":[156],"3\u2032":[158],"end":[159],"CUA110":[162],"(RZ1)":[163],"GUC294":[166],"(RZ7)":[167],"triplets":[168],"mRNA.":[172],"In":[173],"cell-free":[175],"system,":[176],"induced":[179],"cleavage":[180,195,239],"synthetic":[183],"RNA":[184],"substrate":[185,453],"obtained":[186,729],"by":[187,214,302,448,531,546,671,687,696],"cloning":[188],"portion":[190],"mRNA,":[193],"products":[196],"being":[197],"detectable":[198,693],"starting":[199],"from":[200],"ribozyme/substrate":[202],"ratio":[203],"1:0.5.":[205],"Conversely,":[206],"catalytically":[208],"inactive":[209],"mutRZ1":[210,244,293,501],"(which":[211],"was":[212,228,326,390,406,434,456,544,558,610],"produced":[213],"introducing":[215],"mutation":[217],"catalytic":[220,444,656],"core":[221],"active":[224,426,487],"ribozyme":[225,500,660],"RZ1":[226,286,489],"used":[229],"throughout":[232],"study)":[234],"did":[235],"not":[236,559,613],"show":[237],"any":[238],"activity.":[240],"RZ1,":[241],"RZ7,":[242,661],"sequences":[245],"were":[246,300,506,663],"inserted":[247],"into":[248,262],"pRC":[250],"vector":[252,653],"under":[253,377],"cytomega-lovirus":[258],"promoter":[259],"transfected":[261,280,484],"metastatic":[265],"melanoma":[266,344,481,540,555,735],"line":[268],"JR8":[269,315,477,585,606],"overexpressing":[270],"survivin.":[271],"For":[272],"present":[274,727],"study":[275],"selected":[277],"three":[278,438],"stably":[279],"clones":[281,354,464,483],"proven":[282],"endogenously":[284],"express":[285],"(clone":[287,290,294],"RZ1/C),":[288],"RZ7":[289,493],"RZ7/H),":[291],"mutRZ1/B).":[295],"RZ1/C":[296,409,461],"RZ7/H":[298,414,463],"cells":[299,330,345,372,405,418,479,586,607,647,710,718,736,749],"characterized":[301,670],"markedly":[304,705],"lower":[305,680],"protein":[307,474,694],"level":[308],"(68%":[309],"60%":[311],"lower,":[312],"respectively)":[313],"than":[314,465,711],"parental":[316,478],"cells,":[317,395,684],"whereas":[318,396],"negligible":[320],"reduction":[321],"(13%)":[322],"observed":[327,407,435,526],"mutRZ1/B":[329,394,468],"(Figure":[331,419,470],"\u200b(Figure1a).1a).":[332],"To":[333],"evaluate":[334],"effect":[336],"on":[340,719],"susceptibility":[342],"undergo":[347],"cisplatin-induced":[348,529,753],"apoptosis,":[349],"treated":[351],"10":[356],"\u03bcg/ml":[357],"drug":[360],"1":[362],"hour":[363],"determined":[365],"presence":[367],"apoptotic":[369,388,404,709],"nuclei":[370],"stained":[373],"propidium":[375],"iodide":[376],"fluorescence":[378],"micro-scopy":[379],"at":[380],"72":[381],"hours":[382],"after":[383],"treatment.":[384],"A":[385],"very":[386],"modest":[387],"response":[389],"ob-served":[391],"significant":[398],"increase":[399],"percentage":[402,707],"(P":[410,415],"=":[411,416],"0.01)":[412],"0.005)":[417],"\u200b(Figure1b).1b).":[420],"Processing":[421],"caspase-3":[423,443],"subunits":[427],"approximately":[429],"17":[430],"19":[432],"kDa":[433],"all":[437],"drug-treated":[439],"clones.":[440],"However,":[441,599],"activity":[445],"assessed":[447,686],"hydrolysis":[449],"fluorogenic":[452],"N-Acetyl-Asp-Glu-Val-Asp-aldehyde":[454],"(Ac-DEVD-AMC)":[455],"about":[457],"threefold":[458],"higher":[459,706],"clone":[469,669,701],"\u200b(Figure11c).\r\n\r\n\r\n\r\nFigure":[471],"1\r\n\r\n(a)":[472],"(RZ1/C":[490],"clone)":[491,495],"(RZ7/H":[494],"(mutRZ1/B":[502],"clone).":[503],"Western":[504,688],"blots":[505],"probed":[507],"polyclonal":[510],"...\r\n\r\n\r\n\r\nThese":[511],"results":[512,728],"are":[513,581],"agreement":[515],"previous":[518],"finding":[519],"Grossman":[521],"(9),":[524],"who":[525],"enhancement":[527],"YUSAC2":[539],"cells.":[541],"Unlike":[542],"what":[543],"these":[547,748],"authors,":[548],"attenuation":[549],"our":[554],"system":[557],"sufficient":[560],"appreciably":[562],"trigger":[563],"absence":[567],"other":[569],"stimuli.":[570],"Other":[571],"factors":[573],"besides":[574],"survivin,":[575],"such":[576,637,768],"bcl-2":[578],"bcl-xL,":[580],"strongly":[582],"expressed":[583],"may":[588,617],"contribute":[589],"preventing":[591],"programmed":[592],"this":[596],"model.":[598],"it":[600],"should":[601],"be":[602,618],"stressed":[603],"attenuated":[611],"completely":[614],"abrogated.":[615],"It":[616],"below":[621],"certain":[623],"threshold":[624],"insufficient":[626],"determine":[628],"proapoptotic":[630],"effect.":[631],"Interestingly,":[632],"accordance":[635],"hypothesis,":[639],"when":[640],"transduced":[642],"prostate":[645],"DU145":[648],"Moloney-based":[651],"retroviral":[652],"carrying":[654],"sequence":[657],"able":[664],"select":[666],"ribozyme-expressing":[668,700],"almost":[673],"complete":[674],"abrogation":[675],"(99.5%":[679],"compared":[681],"blotting,":[689],"lack":[691],"confocal":[697],"microscopy).":[698],"This":[699],"also":[702,757],"showed":[703],"culture":[713],"(20%":[714],"3%":[716],"overall":[721],"population,":[723],"respectively).\r\n\r\nIn":[724],"conclusion,":[725],"ribozyme-mediated":[732],"approach":[733],"extend":[737],"corroborate":[739],"earlier":[740],"evidence":[741],"indicating":[742],"attenuating":[744],"renders":[747],"more":[750],"susceptible":[751],"apoptosis.":[754],"These":[755],"data":[756],"suggest":[758],"possible":[760],"enhance":[763],"chemosensitivity":[765],"profile":[766],"drug-refractory":[770],"malignancy.":[772]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2013264100","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
